Houston-based University of Texas MD Anderson Cancer Center and the University of Texas at Austin have launched a partnership ...

The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have launched a joint initiative, the ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...

Two cancer patients say the Mayo Clinic quit the 9/11 health program that pays for their care. Advocates fear this may be ...

The AACR poster presentation will provide an update on the data in AML patients most recently presented at the American Society of Hematology (ASH) Annual Meeting 2024 showing that ICT01 administered ...

Vivid dreams can be a symptomatic presentation of mental illness. This type of dream feels real. Learn how they may not ...

The former lawmaker from Utah had undergone treatment for glioblastoma, a malignant brain tumor and received immunotherapy.

Glioblastoma is one of the most deadly and treatment-resistant cancers, according to the National Brain Tumor Society. It is ...

BDC-3042 is a proprietary agonist antibody that targets dectin-2, an immune-activating receptor expressed by tumor-associated macrophages (TAMs). This single-agent, dose-escalation Phase 1 clinical ...

Berubicin showed clinically relevant outcomes comparable to Lomustine across multiple endpoints, but not a statistically significant difference in overall survival, the primary endpoint.The safety pro ...